Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial
CONCLUSION: This accurate prediction model for SMM or worse was developed in a population-based cohort of persons with presumed MGUS and may be used to defer bone marrow sampling and referral to hematology.PRIMARY FUNDING SOURCE: International Myeloma Foundation and the European Research Council.PMID:38560901 | DOI:10.7326/M23-2540
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Elias Eythorsson Saemundur Rognvaldsson Sigrun Thorsteinsdottir Thorir Einarsson Long Elin Ruth Reed Gudrun Asta Sigurdardottir Brynjar Vidarsson Pall Torfi Onundarson Bjarni A Agnarsson Margret Sigurdardottir Isleifur Olafsson Ingunn Thorsteinsdottir Sig Source Type: research
More News: Clinical Trials | Hematology | Iceland Health | Internal Medicine | Myeloma | Statistics | Study